Portfolio Detail New Haven Pharmaceuticals

New Haven Pharmaceuticals

CEO:
Patrick Fourteau

Year Established:
2008

About:
New Haven Pharmaceuticals is a specialty pharmaceuticals company developing proprietary prescription pharmaceuticals that utilize currently marketed drugs or generally recognized as safe active pharmaceutical ingredients for use in therapeutic applications that represent significant market opportunities.

Website
www.newhavenpharma.com

CI Representative:
Daniel Wagner
Managing Director, Investments

back to portfolio